Guo-Ming Shi Selected Research

Biomarkers (Surrogate Marker)

4/2022	KSR2-14-3-3ζ complex serves as a biomarker and potential therapeutic target in sorafenib-resistant hepatocellular carcinoma.
3/2020	Serum PON1 as a biomarker for the estimation of microvascular invasion in hepatocellular carcinoma.
1/2019	Distinct PD-L1/PD1 Profiles and Clinical Implications in Intrahepatic Cholangiocarcinoma Patients with Different Risk Factors.
1/2017	Preoperative Albumin-Bilirubin Score for Postoperative Solitary Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh A Cirrhosis.
12/2011	Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition.
1/2011	Genetic variations in plasma circulating DNA of HBV-related hepatocellular carcinoma patients predict recurrence after liver transplantation.
7/2010	High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma.
11/2008	Osteopontin combined with CD44, a novel prognostic biomarker for patients with hepatocellular carcinoma undergoing curative resection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guo-Ming Shi Research Topics

Disease

48	Hepatocellular Carcinoma (Hepatoma) 02/2024 - 06/2008
47	Neoplasms (Cancer) 01/2024 - 06/2008
14	Neoplasm Metastasis (Metastasis) 05/2023 - 06/2008
8	Cholangiocarcinoma 01/2024 - 03/2015
4	Liver Failure 12/2022 - 01/2019
2	Liver Diseases (Liver Disease) 01/2022 - 01/2019
2	Infections 01/2019 - 01/2019
2	Carcinogenesis 10/2018 - 08/2017
2	Lymphatic Metastasis 01/2014 - 08/2012
1	Disease Progression 01/2023
1	Liver Neoplasms (Liver Cancer) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Ischemia 05/2021
1	Thrombosis (Thrombus) 10/2020
1	Hemorrhage 01/2020
1	Acute Kidney Injury (Acute Renal Failure) 01/2020
1	Portal Hypertension 01/2020
1	Hyperbilirubinemia 01/2019
1	Chronic Idiopathic Jaundice (Dubin Johnson Syndrome) 01/2019
1	Hyperplasia 10/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2017
1	Coinfection 01/2017
1	Fibrosis (Cirrhosis) 01/2017
1	Hepatitis 01/2017

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 04/2022 - 11/2008
6	Proteins (Proteins, Gene)FDA Link 03/2019 - 12/2010
5	Sorafenib (BAY 43-9006)FDA Link 04/2022 - 10/2011
5	TetraspaninsIBA 01/2019 - 02/2009
3	Circular RNAIBA 02/2024 - 01/2019
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2024 - 10/2011
3	RNA (Ribonucleic Acid)IBA 05/2023 - 10/2009
3	Immune Checkpoint InhibitorsIBA 11/2021 - 01/2019
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 01/2011
3	UbiquitinIBA 05/2016 - 11/2012
3	IntegrinsIBA 02/2016 - 11/2008
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 05/2015 - 06/2008
3	Chloroquine (Aralen)FDA LinkGeneric 11/2012 - 10/2011
3	Small Interfering RNA (siRNA)IBA 12/2011 - 10/2009
2	lenvatinibIBA 01/2024 - 01/2023
2	5-hydroxymethylcytosineIBA 01/2023 - 04/2015
2	LigandsIBA 01/2021 - 07/2012
2	Long Noncoding RNAIBA 01/2020 - 01/2019
2	VimentinIBA 01/2020 - 01/2014
2	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2018
2	mortalinIBA 01/2019 - 08/2017
2	BilirubinIBA 01/2019 - 01/2017
2	Selenium-Binding ProteinsIBA 01/2018 - 01/2018
2	Cadherins (E-Cadherin)IBA 01/2014 - 10/2009
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2011 - 07/2010
1	Gemcitabine FDA Link 01/2024
1	TCF Transcription FactorsIBA 10/2023
1	Low Density Lipoprotein Receptor-Related Protein-6IBA 10/2023
1	PlasticsIBA 10/2023
1	InflammasomesIBA 05/2023
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 05/2023
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 01/2023
1	pemigatinibIBA 01/2023
1	toripalimabIBA 01/2023
1	KSR-1 protein kinaseIBA 04/2022
1	avatrombopagIBA 01/2022
1	Adenosine (Adenocard)FDA LinkGeneric 11/2021
1	CTLA-4 AntigenIBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	apatinibIBA 10/2020
1	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 01/2020
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2020
1	TerlipressinIBA 01/2020
1	Triose-Phosphate Isomerase (Triosephosphate Isomerase)IBA 01/2020
1	centromere protein FIBA 07/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019
1	Sincalide FDA Link 01/2019
1	GlucocorticoidsIBA 01/2019
1	Competitive Endogenous RNAIBA 01/2019
1	LipidsIBA 10/2018
1	Nonesterified Fatty Acids (NEFA)IBA 10/2018
1	Glutathione Transferase (Glutathione S-Transferase)IBA 07/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	NLR ProteinsIBA 01/2018
1	NucleotidesIBA 01/2018
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2017
1	Hepatitis B e AntigensIBA 01/2017
1	AlbuminsIBA 01/2017
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2017
1	Membrane Proteins (Integral Membrane Proteins)IBA 12/2016
1	Annexin A2 (Annexin II)IBA 05/2016
1	Monoclonal AntibodiesIBA 02/2016
1	Tetraspanin 24IBA 02/2016
1	MAP Kinase Kinase Kinase 4IBA 12/2015
1	Growth Factor ReceptorsIBA 10/2015
1	Protein Tyrosine PhosphatasesIBA 10/2015
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 05/2015
1	human PSMC5 proteinIBA 05/2015
1	Ubiquitin-Specific ProteasesIBA 05/2015
1	Protein Isoforms (Isoforms)IBA 03/2015

Therapy/Procedure

10	Therapeutics 02/2024 - 10/2011
7	Hepatectomy 12/2022 - 03/2014
5	Immunotherapy 01/2023 - 11/2013
2	Drug Therapy (Chemotherapy) 01/2023 - 01/2019
1	Length of Stay 01/2019